159 related articles for article (PubMed ID: 3044581)
21. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
22. Oncogene patterns in breast and ovarian carcinomas.
Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
[TBL] [Abstract][Full Text] [Related]
23. Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma.
Kitagawa Y; Ueda M; Ando N; Ozawa S; Shimizu N; Kitajima M
Clin Cancer Res; 1996 May; 2(5):909-14. PubMed ID: 9816249
[TBL] [Abstract][Full Text] [Related]
24. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
Kern JA; Slebos RJ; Top B; Rodenhuis S; Lager D; Robinson RA; Weiner D; Schwartz DA
J Clin Invest; 1994 Feb; 93(2):516-20. PubMed ID: 7906694
[TBL] [Abstract][Full Text] [Related]
25. [Metastasis related genes and malignancy in human esophageal, gastric and colorectal cancers].
Tahara E; Kuniyasu H; Nakayama H; Yasui W; Yokozaki H
Gan To Kagaku Ryoho; 1993 Feb; 20(3):326-31. PubMed ID: 8094950
[TBL] [Abstract][Full Text] [Related]
26. ERBB2 amplifications in esophageal adenocarcinoma.
Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
[TBL] [Abstract][Full Text] [Related]
27. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas.
Lin L; Miller CT; Contreras JI; Prescott MS; Dagenais SL; Wu R; Yee J; Orringer MB; Misek DE; Hanash SM; Glover TW; Beer DG
Cancer Res; 2002 Sep; 62(18):5273-9. PubMed ID: 12234996
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
29. Oncogene amplification detected by in situ hybridization in radiation-induced skin cancers in rats.
Jin Y; Burns FJ; Garte SJ
Radiat Res; 1992 Nov; 132(2):193-9. PubMed ID: 1438701
[TBL] [Abstract][Full Text] [Related]
30. ras mutations and expression in head and neck squamous cell carcinomas.
Yarbrough WG; Shores C; Witsell DL; Weissler MC; Fidler ME; Gilmer TM
Laryngoscope; 1994 Nov; 104(11 Pt 1):1337-47. PubMed ID: 7968162
[TBL] [Abstract][Full Text] [Related]
31. Two independent amplification events on chromosome 7 in glioma: amplification of the epidermal growth factor receptor gene and amplification of the oncogene MET.
Wullich B; Sattler HP; Fischer U; Meese E
Anticancer Res; 1994; 14(2A):577-9. PubMed ID: 8017863
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of c-met proto-oncogene but not epidermal growth factor receptor or c-erbB-2 in primary human colorectal carcinomas.
Liu C; Park M; Tsao MS
Oncogene; 1992 Jan; 7(1):181-5. PubMed ID: 1741162
[TBL] [Abstract][Full Text] [Related]
33. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
Mitra AB; Murty VV; Pratap M; Sodhani P; Chaganti RS
Cancer Res; 1994 Feb; 54(3):637-9. PubMed ID: 7905784
[TBL] [Abstract][Full Text] [Related]
34. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.
Zhang X; Silva E; Gershenson D; Hung MC
Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708
[TBL] [Abstract][Full Text] [Related]
35. Hyperproduction and gene amplification of the epidermal growth factor receptor in squamous cell carcinomas.
Hunts J; Ueda M; Ozawa S; Abe O; Pastan I; Shimizu N
Jpn J Cancer Res; 1985 Aug; 76(8):663-6. PubMed ID: 2995289
[TBL] [Abstract][Full Text] [Related]
36. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
37. Oncogenes related to head and neck cancer.
Issing WJ; Wustrow TP; Heppt WJ
Anticancer Res; 1993; 13(6B):2541-51. PubMed ID: 8135494
[TBL] [Abstract][Full Text] [Related]
38. Expression of the c-erbB-2 gene encoding a growth factor receptor.
Yamamoto T; Akiyama T; Yokota J; Mori S; Toyoshima K
Princess Takamatsu Symp; 1986; 17():203-10. PubMed ID: 3455415
[TBL] [Abstract][Full Text] [Related]
39. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
[TBL] [Abstract][Full Text] [Related]
40. Specificity of proto-oncogene amplification in human malignant diseases.
Masuda H; Battifora H; Yokota J; Meltzer S; Cline MJ
Mol Biol Med; 1987 Aug; 4(4):213-27. PubMed ID: 3670047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
